Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if it wasn’t for a creepy, ...
Opinion
Sentinel & Enterprise on MSNOpinion
Editorial: Sheriff marshals impetus for novel drug-therapy center
Although he’s had considerable success in treating substance abuse among inmates, Middlesex Sheriff Peter Koutoujian realized that a jail/prison wasn’t the most effective setting in which to treat ...
When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in ...
Appointment of Dr. Rahul Patel as Senior Vice President of Clinical Development strengthens leadership team and provides critical support to accelerate clinical development of lead programWALTHAM, ...
GENFIT’s 2025 Universal Registration Document includes, in particular: The Statutory Auditors’ reports on the annual and consolidated financial statements and related-party agreements, The table ...
MA marijuana overhaul bill nears passage; ME cannabis lounge proposal defeated; How to handle high-THC marijuana?; MO ...
Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal ...
From In the Matter of K.P., decided June 26, 2024 by the Massachusetts District Court Appellate Division (Judge Thomas ...
Biogen (BIIB) partners with Alloy Therapeutics for antisense oligonucleotide platform access. RBC cuts price target to $213 while maintaining Outperform.
Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced its wholly-owned subsidiary, Halozyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results